Lagumbay, Althea T.

HRN: 28-51-10  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/31/2026
AMPICILLIN 250MG (VIAL)
01/31/2026
02/04/2026
IV
70 Mg
Q 12
Prematurity
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: